Minnetonka, MNNCT06452316Now EnrollingIRB Ready

Limbal Stem Cell Deficiency Clinical Trial in Minnetonka, MN

Access cutting-edge limbal stem cell deficiency treatment through this clinical trial at a research site in Minnetonka. Study-provided care at no cost to qualified participants.

Sponsored by Claris Biotherapeutics, Inc.

Quick Self-Assessment

See if you qualify for this Minnetonka location

Preparing your pre-screening questions…

Expert Care in Minnetonka

Access limbal stem cell deficiency specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related limbal stem cell deficiency treatment provided free

Apply for This Minnetonka Location

Check if you qualify for this limbal stem cell deficiency clinical trial in Minnetonka, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Minnetonka

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Minnetonka site if eligible
  4. 4Begin participation

About This Limbal Stem Cell Deficiency Study in Minnetonka

This study will enroll subjects with qualifying limbal stem cell deficiency (LSCD). All subjects will receive CSB-001 investigational drug in either one or both study eyes. The study is comprised of two identical phases (Dosing Phase I and II) of test article dosing separated by a 31- to 40-day period, the Dosing Holiday, where no test article is administered. Dosing Phase II is followed by an observational, noninterventional phase (Observation Phase).

Sponsor: Claris Biotherapeutics, Inc.

Who Can Participate

Inclusion Criteria

Have an area of the central 5 mm zone of cornea affected, presence of at least one clinical sign observed by slit-lamp examination with white light and/or cobalt blue light, fluorescein, and a Wratten filter, and at least one clinical sign observed with AS-OCT.
If dosing with Acthar at time of Screening Visit, must have a history of stable dosing for approximately 8 weeks, plan to maintain the same Acthar treatment dose and regimen, and have demonstrated little to no improvement in severity of LSCD.
Sponsor written confirmation of qualifying LSCD diagnosis.
Inflammation associated with LSCD or other non-infectious inflammation that will not interfere with subject's participation.

Exclusion Criteria

Any active ocular infection (bacterial, viral, fungal, or protozoan) in either eye.
Ocular surgery within 30 days of Day 0 where investigator assesses that healing is not considered complete/stable.
Planned ocular surgery on or before Week 20 visit.
Presence or history of any ocular or systemic disorder, condition, or procedure that might hinder the efficacy of the study treatment or its evaluation, or could interfere with the interpretation of study results, in the opinion of the investigator. Note: Other inclusion/exclusion criteria apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Minnetonka?

Yes, this clinical trial (NCT06452316) has an active research site in Minnetonka, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Limbal Stem Cell Deficiency Treatment Options in Minnetonka, MN

If you're searching for limbal stem cell deficiency treatment options in Minnetonka, MN, this clinical trial (NCT06452316) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Minnetonka research site is actively enrolling participants for this clinical trial. You'll receive care from experienced limbal stem cell deficiency specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all limbal stem cell deficiency clinical trials near you to find additional studies recruiting in your area.

More Interstitial Cystitis Trials in Minnetonka, MN

See all interstitial cystitis clinical trials recruiting in Minnetonka — not just this study.

Browse Interstitial Cystitis Trials in Minnetonka →

Browse More Trials by Condition

Interstitial Cystitis TrialsAll Conditions →

Ready to Join in Minnetonka?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Minnetonka, MN